CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $99,829
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$99,829. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-29 | Love Douglas President & CEO | Option exercise · Stock Option (Right to Buy) | −3,750 | 64,346 | ||
| 2021-03-25 | Yednock Ted EVP & Chief Scientific Officer | Option exercise | +15,000 | $1.41 | $21K | 15,000 |
| 2021-03-25 | Yednock Ted EVP & Chief Scientific Officer | Option exercise | +1,175 | $5.11 | $6K | 16,175 |
| 2021-03-25 | Yednock Ted EVP & Chief Scientific Officer | Sale | −10,258 | $28.54 | $293K | 5,917 |
| 2021-03-25 | Yednock Ted EVP & Chief Scientific Officer | Sale | −5,680 | $29.21 | $166K | 237 |
| 2021-03-25 | Yednock Ted EVP & Chief Scientific Officer | Sale | −237 | $29.96 | $7K | 0 |
| 2021-03-25 | Yednock Ted EVP & Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −15,000 | 40,615 | ||
| 2021-03-25 | Yednock Ted EVP & Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −1,175 | 69,129 | ||
| 2021-03-24 | Keswani Sanjay EVP & Chief Medical Officer | Option exercise | +3,995 | $7.49 | $30K | 3,995 |
| 2021-03-24 | Keswani Sanjay EVP & Chief Medical Officer | Sale | −3,995 | $30.17 | $121K | 0 |
| 2021-03-24 | Keswani Sanjay EVP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −3,995 | 182,956 | ||
| 2021-03-23 | Lew Jennifer EVP & Chief Financial Officer | Option exercise | +5,000 | $7.49 | $37K | 7,000 |
| 2021-03-23 | Lew Jennifer EVP & Chief Financial Officer | Sale | −1,400 | $27.51 | $39K | 5,600 |
| 2021-03-23 | Lew Jennifer EVP & Chief Financial Officer | Sale | −1,800 | $28.43 | $51K | 3,800 |
| 2021-03-23 | Lew Jennifer EVP & Chief Financial Officer | Sale | −1,800 | $29.16 | $52K | 2,000 |
| 2021-03-23 | Lew Jennifer EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 150,793 | ||
| 2021-02-25 | Keswani Sanjay EVP & Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2021-02-25 | Yednock Ted EVP & Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2021-02-25 | Lew Jennifer EVP & Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2021-02-25 | Overdorf Michael EVP & Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 |
Page 13 of 15 · 292 trades